Wednesday, July 15, 2009

MannKind Announces Positive New Market Survey Information Regarding AFRESA®

MannKind Corporation today released new information related to the market potential for AFRESA, MannKind's ultra rapid-acting insulin.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)